WASHINGTON — If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Revolution Medicines (RVMD – Research Report) today and set ...

NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to ...

On Thursday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.18 which represents a slight increase of $0.22 or 2.46% from the prior close of $8.96. The stock opened at $9.16 and ...